IgG

Hepatitis B marker

IgM antibodies - Hepatitis B

IgM antibodies to Hepatitis B are an important part of the immune system's response to an ongoing or recently occurred Hepatitis B infection.

What are IgM antibodies to Hepatitis B?

IgM antibodies to Hepatitis B are specific proteins produced by the body's immune system in response to an early Hepatitis B infection. These antibodies play a crucial role in fighting the initial infection and can help identify an ongoing or recently occurred Hepatitis B infection.

Why are IgM antibodies to Hepatitis B analyzed?

Analysis of IgM antibodies to Hepatitis B is performed for several reasons:

  • Diagnosing Recently Occurred Infection: Testing for IgM antibodies to Hepatitis B can indicate whether a person has recently been infected with the virus. These antibodies are particularly useful for identifying early stages of the disease.
  • Confirming Acute Hepatitis: High levels of IgM antibodies to Hepatitis B can indicate acute Hepatitis B infection, which is the most contagious phase of the disease.
  • Monitoring Treatment and Disease Progression: For individuals with acute Hepatitis B, testing for IgM antibodies can be used to monitor the progression of the disease and assess the effectiveness of treatment.

Low levels of IgM antibodies to Hepatitis B

Low levels of IgM antibodies to Hepatitis B may indicate that a person has not recently been infected or that the infection has progressed to a later stage.

High levels of IgM antibodies to Hepatitis B

High levels of IgM antibodies typically indicate an ongoing or recently occurred Hepatitis B infection, especially during the acute phase of the disease.

However, it's important to note that high levels of IgM antibodies do not necessarily indicate that a person is in the acute stage of the infection. Sometimes, high levels of IgM antibodies can persist for some time even after the acute phase has passed.

The results of these tests should always be interpreted in conjunction with other clinical and laboratory data to obtain an accurate assessment of infection status and disease progression.

Testing for IgM antibodies to Hepatitis B before IVF treatment

Prior to IVF treatment, it is important to test for IgM antibodies to Hepatitis B to ensure that the prospective mother is not in an active infection phase, as the infection can affect the pregnancy and the health of the unborn child. Additionally, it is part of routine healthcare to ensure a safe pregnancy and delivery.